| scholarly article | Q13442814 |
| P2093 | author name string | Chantal A Rivera | |
| P2860 | cites work | Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 |
| Body fat distribution, insulin resistance, and metabolic diseases | Q28248535 | ||
| The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis | Q28345942 | ||
| Nonalcoholic Steatohepatitis in Children | Q29013392 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein | Q29615189 | ||
| TLR4 links innate immunity and fatty acid-induced insulin resistance | Q29617577 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| Is NASH underdiagnosed among African Americans? | Q30309598 | ||
| Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice | Q31045022 | ||
| Leptin in the regulation of immunity, inflammation, and hematopoiesis | Q33922050 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase | Q34216687 | ||
| Sex differences in the relation of visceral adipose tissue accumulation to total body fatness | Q34354997 | ||
| Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression | Q34534899 | ||
| Update on nonalcoholic fatty liver disease | Q34548921 | ||
| Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis | Q34713484 | ||
| Nonalcoholic fatty liver disease in the pediatric population | Q35872168 | ||
| Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis | Q36050135 | ||
| Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis | Q36168809 | ||
| Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients | Q36573693 | ||
| Non-alcoholic fatty liver disease: further expression of the metabolic syndrome | Q36734086 | ||
| The multifaceted associations of hepatobiliary disease and diabetes | Q36864416 | ||
| Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes | Q37375694 | ||
| Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver | Q38287738 | ||
| Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. | Q38289678 | ||
| Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation | Q38299128 | ||
| Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis | Q38308819 | ||
| Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease | Q38358419 | ||
| Prevalence and trends in overweight among US children and adolescents, 1999-2000 | Q39513388 | ||
| Regulation of hepatic lipase and serum lipoproteins by sex steroids | Q39756753 | ||
| Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages | Q40212651 | ||
| Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients | Q40431091 | ||
| Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. | Q40816506 | ||
| Cardiovascular risk factors in women | Q41486308 | ||
| Beneficial effects of cytokine induced hyperlipidemia. | Q41748634 | ||
| Prevalence and Predictors of Asymptomatic Liver Disease in Patients Undergoing Gastric Bypass Surgery | Q42612932 | ||
| Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia | Q42817378 | ||
| Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats | Q42846526 | ||
| Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals | Q43693276 | ||
| The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women | Q44067750 | ||
| Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers | Q44081111 | ||
| Rodent nutritional model of non‐alcoholic steatohepatitis: Species, strain and sex difference studies | Q44612122 | ||
| Gender differences in the effect of type 2 diabetes on serum lipids, pre-heparin plasma lipoprotein lipase mass and other metabolic parameters in Japanese population | Q44633775 | ||
| Sex differences in choline-deficient diet-induced steatohepatitis in mice | Q44735932 | ||
| Minodronate, a nitrogen-containing bisphosphonate, is a promising remedy for treating patients with diabetic retinopathy | Q46745325 | ||
| Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency | Q46828260 | ||
| Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. | Q46848107 | ||
| Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. | Q46854553 | ||
| Independent predictors of steatohepatitis and fibrosis in Asian Indian patients with non-alcoholic steatohepatitis | Q46887855 | ||
| Experimental evidence of obstructive sleep apnea syndrome as a second hit accomplice in nonalcoholic steatohepatitis pathogenesis | Q48451139 | ||
| Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver | Q48460142 | ||
| Chronic intermittent hypoxia predisposes to liver injury | Q48473495 | ||
| Chronic liver injury during obstructive sleep apnea | Q48550777 | ||
| Gender difference in postprandial lipemia : importance of visceral adipose tissue accumulation. | Q51560450 | ||
| Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients. | Q51754258 | ||
| Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients. | Q53575022 | ||
| Regional patterns of fat distribution. | Q53751502 | ||
| Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance | Q56742768 | ||
| Chemokines control fat accumulation and leptin secretion by cultured human adipocytes | Q57076426 | ||
| Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts | Q62735381 | ||
| Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women | Q77931909 | ||
| Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients | Q79275904 | ||
| Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis | Q80456156 | ||
| The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome | Q80565990 | ||
| Influence of age and gender in Japanese patients with non-alcoholic steatohepatitis | Q80566517 | ||
| Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis | Q80691827 | ||
| Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2 | Q81230296 | ||
| Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery | Q82516127 | ||
| P433 | issue | 2 | |
| P921 | main subject | steatohepatitis | Q2335423 |
| non-alcoholic steatohepatitis | Q28692677 | ||
| P304 | page(s) | 109-114 | |
| P577 | publication date | 2008-07-29 | |
| P1433 | published in | Pathophysiology | Q15716690 |
| P1476 | title | Risk factors and mechanisms of non-alcoholic steatohepatitis | |
| P478 | volume | 15 |
| Q41849677 | Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression |
| Q36803083 | Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis |
| Q35776345 | FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxis |
| Q90643050 | Germacrone cooperates with dexmedetomidine to alleviate high-fat diet-induced type 2 diabetes mellitus via upregulating AMPKα1 expression |
| Q43179101 | Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease |
| Q38000540 | Metabolic syndrome and risk factors for non-alcoholic fatty liver disease |
| Q34102001 | Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings |
| Q33907632 | Steatosis and steatohepatitis: complex disorders |
| Q45988432 | The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer. |
Search more.